☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Risk
BridgeBio and Origin's Nulibry (fosdenopterin) Receives the US FDA's Approval as the First Therapy to Reduce the Risk of Mortality...
March 1, 2021
Merck and Bayer Receive the US FDA's Priority Review for Vericiguat to Reduce the Risk of CV Death in Patients with Symptomatic Ch...
July 16, 2020
Roche's cobas HPV Test Receives the US FDA's Approval for cobas 6800/8800 System to Identify Women at Risk for Cervical Cancer
April 21, 2020
Amgen's Corlanor (ivabradine) Receives FDA's Approval to Reduce Risk of Hospitalization for Worsening Heart Failure in Patients wi...
April 15, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.